|
1
|
Chen W, Zheng R, Zhang S, Zeng H, Xia C,
Zuo T, Yang Z, Zou X and He J: Cancer incidence and mortality in
China, 2013. Cancer Lett. 401:63–71. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van Leeuwen CM, Oei AL, Chin KWTK, Crezee
J, Bel A, Westermann AM, Buist MR, Franken NAP, Stalpers LJA and
Kok HP: A short time interval between radiotherapy and hyperthermia
reduces in-field recurrence and mortality in women with advanced
cervical cancer. Radiat Oncol. 12:752017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tewari KS, Sill MW, Long HJ III, Penson
RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao
MM, et al: Improved survival with bevacizumab in advanced cervical
cancer. N Engl J Med. 370:734–743. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang H, Tao L, Ni T, Gu H, Jin F, Dai X,
Feng J, Ding Y, Xiao W, Guo S, et al: Anticancer efficacy of the
ethyl acetate extract from the traditional Chinese medicine herb
Celastrus orbiculatus against human gastric cancer. J
Ethnopharmacol. 205:147–157. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kumar D, Basu S, Parija L, Rout D, Manna
S, Dandapat J and Debata PR: Curcumin and Ellagic acid
synergistically induce ROS generation, DNA damage, p53 accumulation
and apoptosis in HeLa cervical carcinoma cells. Biomed Pharmacoth.
81:31–37. 2016. View Article : Google Scholar
|
|
6
|
Xu QY: The clinical value of local
application of compound zedoary turmeric oil suppository for
cervical human papilloma virus infection. Med Inform. 2:337–338.
2015.(In Chinese).
|
|
7
|
Zhang X, Zhang Y and Li Y: β-elemene
decreases cell invasion by upregulating E-cadherin expression in
MCF-7 human breast cancer cells. Oncol Rep. 30:745–750. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bao F, Qiu J and Zhang H: Potential role
of β-elemene on histone H1 in the H22 ascites hepatoma cell line.
Mol Med Rep. 6:185–190. 2012.PubMed/NCBI
|
|
9
|
Wang G, Li X, Huang F, Zhao J, Ding H,
Cunningham C, Coad JE, Flynn DC, Reed E and Li QQ: Antitumor effect
of beta-elemene in non-small-cell lung cancer cells is mediated via
induction of cell cycle arrest and apoptotic cell death. Cell Mol
Life Sci. 62:881–893. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yao YQ, Ding X, Jia YC, Huang CX, Wang YZ
and Xu YH: Anti-tumor effect of beta-elemene in glioblastoma cells
depends on p38 MAPK activation. Cancer Lett. 264:127–134. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liang D, Yang M, Guo B, Yang L, Cao J and
Zhang X: HIF-1α induced by β-elemene protects human osteosarcoma
cells from undergoing apoptosis. J Cancer Res Clin Oncol.
138:1865–1877. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Polakis P: Wnt signaling and cancer. Genes
Dev. 14:1837–1851. 2000.PubMed/NCBI
|
|
13
|
Chen C, Zhao M, Tian A, Zhang X, Yao Z and
Ma X: Aberrant activation of Wnt/β-catenin signaling drives
proliferation of bone sarcoma cells. Oncotarget. 6:17570–17583.
2015.PubMed/NCBI
|
|
14
|
Lu JJ, Dang YY, Huang M, Xu WS, Chen XP
and Wang YT: Anti-cancer properties of terpenoids isolated from
Rhizoma Curcumae. J Ethnopharmacol. 143:406–411. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li QQ, Wang G, Huang F, Banda M and Reed
E: Antineoplastic effect of beta-elemene on prostate cancer cells
and other types of solid tumor cells. J Pharm Pharmacol.
62:1018–1027. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao YS, Zhu TZ, Chen YW, Yao YQ, Wu CM,
Wei ZQ, Wang W and Xu YH: β-elemene inhibits Hsp90/Raf-1 molecular
complex inducing apoptosis of glioblastoma cells. J Neurooncol.
107:307–314. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li CL, Chang L, Guo L, Zhao D, Liu HB,
Wang QS, Zhang P, Du WZ, Liu X, Zhang HT, et al: β-elemene induces
caspase-dependent apoptosis in human glioma cells in vitro through
the upregulation of Bax and Fas/FasL and downregulation of Bcl-2.
Asian Pac J Cancer Prev. 15:10407–10412. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu T, Zhao Y, Zhang J, Li L, Zou L, Yao Y
and Xu Y: β-elemene inhibits proliferation of human glioblastoma
cells and causes cell-cycle G0/G1 arrest via mutually compensatory
activation of MKK3 and MKK6. Int J Oncol. 38:419–426.
2011.PubMed/NCBI
|
|
19
|
Jares P, Colomera D and Campo E: Genetic
and molecular pathogenesis of mantle cell lymphoma: Perspectives
for new targeted therapeutics. Nat Rev Cancer. 7:750–762. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Diehl JA: Cycling to cancer with cyclin
D1. Cancer Biol Ther. 1:226–231. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo Q, Dong B, Nan F, Guan D and Zhang Y:
5-Aminolevulinic acid photodynamic therapy in human cervical cancer
via the activation of microRNA-143 and suppression of the Bcl-2/Bax
signaling pathway. Mol Med Rep. 14:544–550. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Adams JM and Cory S: The Bcl-2 apoptotic
switch in cancer development and therapy. Oncogene. 26:1324–1337.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Levine AJ and Oren M: The first 30 years
of p53: Growing ever more complex. Nat Rev Cancer. 9:749–758. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yan Y, Liang H, Li T, Li M, Li R, Qin X
and Li S: The MMP-1, MMP-2, and MMP-9 gene polymorphisms and
susceptibilityto bladder cancer: A meta-analysis. Tumour Biol.
35:3047–3052. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao H, Yuan X, Jiang J, Wang P, Sun X,
Wang D and Zheng Q: Antimetastatic effects of licochalcone B on
human bladder carcinoma T24 by inhibition of matrix
metalloproteinases9 and NF-κB activity. Basic Clin Pharmacol
Toxicol. 115:527–533. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hoffmeyer K, Raggioli A, Rudloff S, Anton
R, Hierholzer A, Del Valle I, Hein K, Vogt R and Kemler R:
Wnt/β-catenin signaling regulates telomerase in stem cells and
cancer cells. Science. 336:1549–1554. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Valenta T, Hausmann G and Basler K: The
many faces and functions of β-catenin. EMBO J. 31:2714–2736. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Koff JL, Ramachandiran S and
Bernal-Mizrachi L: A time to kill: Targeting apoptosis in cancer.
Int J Mol Sci. 16:2942–2955. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu K, Ma L and Zhu J: miR-483-5p promotes
growth, invasion and self-renewal of gastric cancer stem cells by
Wnt/β-catenin signaling. Mol Med Rep. 14:3421–3428. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rother K, Johne C, Spiesbach K, Haugwitz
U, Tschöp K, Wasner M, Klein-Hitpass L, Möröy T, Mössner J and
Engeland K: Identification of Tcf-4 as a transcriptional target of
p53 signalling. Oncogene. 23:3376–3384. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang J, Shou J and Chen X: Dickkopf-1, an
inhibitor of the Wnt signaling pathway, is induced by p53.
Oncogene. 30:1843–1848. 2000. View Article : Google Scholar
|
|
32
|
Kim NH, Kim HS, Kim NG, Lee I, Choi HS, Li
XY, Kang SE, Cha SY, Ryu JK, Na JM, et al: p53 and microRNA-34 are
suppressors of canonical Wnt signaling. Sci Signal. 4:ra712011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li L, Xu L, Qu X, Zhao M, Yu P, Kang J,
Liu Y and Hu X: Cbl-regulated Akt and ERK signals are involved in
β-elemene-induced cell apoptosis in lung cancer cells. Mol Med Rep.
4:1243–1246. 2011.PubMed/NCBI
|
|
34
|
Wu B, Crampton SP and Hughes CC: Wnt
signaling induces matrix metalloproteinase expression and regulates
T cell transmigration. Immunity. 26:227–239. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Imai K, Yokohama Y, Nakanishi I, Ohuchi E,
Fujii Y, Nakai N and Okada Y: Matrix metalloproteinase 7
(matrilysin) from human rectal carcinoma cells. Activation of the
precursor, interaction with other matrix metalloproteinases and
enzymic properties. J Biol Chem. 270:6691–6697. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang X, Li Y, Zhang Y, Song J, Wang Q,
Zheng L and Liu D: Beta-elemene blocks epithelial-mesenchymal
transition in human breastcancer cell line MCF-7 through
Smad3-mediated down-regulation of nuclear transcription factors.
PLoS One. 8:e587192013. View Article : Google Scholar : PubMed/NCBI
|
